Je. Friedman et al., REDUCED INSULIN-RECEPTOR SIGNALING IN THE OBESE SPONTANEOUSLY HYPERTENSIVE KOLETSKY RAT, American journal of physiology: endocrinology and metabolism, 36(5), 1997, pp. 1014-1023
Insulin resistance is associated with both obesity and hypertension. H
owever, the cellular mechanisms of insulin resistance in genetic model
s of obese-hypertension have not been identified. The objective of the
present study was to investigate the effects of genetic obesity on a
background of inherited hypertension on initial components of the insu
lin signal transduction pathway and glucose transport in skeletal musc
le and liver. Oral glucose tolerance testing in SHROB demonstrated a s
ustained postchallenge elevation in plasma glucose at 180 and 240 min
compared with lean spontaneously hypertensive rat (SHR) littermates, w
hich is suggestive of glucose intolerance. Fasting plasma insulin leve
ls were elevated 18-fold in SHROB. The rate of insulin-stimulated 3-O-
methylglucose transport was reduced 68% in isolated epitrochlearis mus
cles from the SHROB compared with SHR. Insulin-stimulated tyrosine pho
sphorylation of the insulin receptor beta-subunit and insulin receptor
substrate-1 (IRS-1) in intact skeletal muscle of SHROB was reduced by
36 and 23%, respectively, compared with SHR, due primarily to 32 and
60% decreases in insulin receptor and IRS-1 protein expression, respec
tively. The amounts of p85 alpha regulatory subunit of phosphatidylino
sitol-3-kinase and GLUT-4 protein were reduced by 28 and 25% in SHROB
muscle compared with SHR. In the liver of SHROB, the effect of insulin
on tyrosine phosphorylation of IRS-1 was not changed, but insulin rec
eptor phosphorylation was decreased by 41%, compared with SHR, due to
a 30% reduction in insulin receptor levels. Our observations suggest t
hat the leptin receptor mutation f alpha(k) imposed on a hypertensive
background results in extreme hyperinsulinemia, glucose intolerance, a
nd decreased expression of postreceptor insulin signaling proteins in
skeletal muscle. Despite these changes, hypertension is not exacerbate
d in SHROB compared with SHR, suggesting these metabolic abnormalities
may not contribute to hypertension in this model of Syndrome X.